Hereditary hemochromatosis is a genetic condition in which the body absorbs too much iron from food and has no efficient way to get rid of the excess. Over years or decades, that iron accumulates in the liver, heart, joints, and hormone-producing glands, eventually damaging them. It is one of the most common inherited disorders in people of Northern European descent, yet the majority of those carrying the responsible gene variants never develop serious illness, which makes it both underdiagnosed and poorly understood by the general public.
How Iron Builds Up
Under normal circumstances, a hormone called hepcidin acts as the body’s iron thermostat. When iron levels in the blood are adequate, hepcidin signals the cells lining the gut to slow down iron absorption. In hereditary hemochromatosis, mutations in genes that regulate hepcidin production leave hepcidin levels chronically low. Without that brake, gut cells keep absorbing dietary iron at full speed, and immune cells called macrophages release stored iron back into the bloodstream more readily than they should.1Biochimica et Biophysica Acta (BBA) – Molecular Cell Research. Hepcidin and iron homeostasis
The extra iron saturates transferrin, the protein that normally carries it safely through the blood, and spills over into a free-floating form that gets rapidly taken up by liver cells, heart muscle cells, and cells in the pancreas and pituitary gland. The liver takes the biggest hit because it is especially good at soaking up this unbound iron but relatively limited in its ability to export it back out. That imbalance is why the liver is almost always the first organ to show damage.
The Genetics and Who Gets Sick
The most common form, sometimes called type 1 or classical hemochromatosis, is caused by mutations in a gene called HFE. Two variants matter most. C282Y is the main one, and the vast majority of people who develop clinical disease are homozygous for it, meaning they inherited a copy from each parent. A second variant, H63D, is more common in the population but far less likely to cause trouble on its own. People who carry one copy of each (compound heterozygotes) sometimes show higher-than-normal iron levels but rarely develop organ damage.2PubMed Central. HFE C282Y/H63D Compound Heterozygotes Are at Low Risk of Hemochromatosis-Related Morbidity
Even among C282Y homozygotes, the picture is far from straightforward. A large study using electronic medical records found that only about a quarter of men and roughly 14% of women with two copies of C282Y were ever diagnosed with hemochromatosis.3PubMed Central. Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network Some reviews put the proportion who develop outright clinical disease even lower, possibly under 5%, though the exact figure remains debated because researchers use different definitions of what counts as “clinically significant.”4PubMed Central. Clinical Penetrance of C282Y Homozygous HFE Haemochromatosis The gap between carrying the genotype and getting sick is one of the reasons population-wide genetic screening has been so controversial.
Women are protected to a degree by menstruation and pregnancy, both of which remove iron from the body on a regular basis. That is a big part of why men are diagnosed more often and tend to present with more severe iron loading at an earlier age.
Rarer Forms You Might Not Hear About
Classical HFE hemochromatosis dominates the conversation, but several other genetic types exist, each caused by mutations in a different gene involved in hepcidin signaling or iron transport.
Juvenile hemochromatosis (type 2) is the most aggressive. It causes severe iron overload before age 30 and affects men and women equally. Heart failure and hormonal dysfunction, especially loss of sex hormones due to pituitary iron deposits, are its hallmarks. Without treatment, patients often die of heart complications before 40.5PubMed Central. Non-HFE hemochromatosis Fortunately, it is extremely rare.
Ferroportin disease (type 4) stands apart from all the others. It is inherited in a dominant pattern, meaning a single mutated copy of the SLC40A1 gene is enough to cause problems. Patients typically present with low or normal transferrin saturation rather than the high levels seen in classical hemochromatosis, and iron tends to build up inside macrophages rather than in liver cells. This can cause mild anemia, and these patients often tolerate phlebotomy poorly.6Journal of Clinical and Translational Hepatology. Primary Non-HFE Hemochromatosis: A Review Recent registry data show that ferroportin disease accounts for most non-HFE cases, and it turns out to be surprisingly common in African populations, where certain SLC40A1 variants are carried by roughly one in 200 people.7Genetics in Medicine. The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data By contrast, HFE hemochromatosis is vanishingly rare in East Asian populations, where the C282Y variant is nearly absent.8Genetics in Medicine. The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data
What Damage Looks Like
Iron overload is slow and silent. Many people accumulate excess iron for decades before symptoms appear, and the early signs are maddeningly vague: fatigue, joint stiffness, general malaise. By the time specific organ damage shows up, the iron burden can be substantial.
The liver is the primary target. Progressive iron loading leads to inflammation, fibrosis, and eventually cirrhosis. In one long-term cohort followed for a median of about 15 years, every patient who developed liver cancer had cirrhosis at baseline; none of the patients without cirrhosis developed cancer during follow-up.9Scientific Reports. Risk profiling for cirrhosis and hepatocellular carcinoma in HFE hemochromatosis using mobilizable iron stores and alcohol consumption This echoes broader observations that liver cancer risk in hemochromatosis is concentrated almost entirely in people who already have cirrhosis.10PubMed. Iron, hemochromatosis, and hepatocellular carcinoma
Iron deposits in the pancreas can impair insulin production and cause diabetes. The pituitary gland is also vulnerable; iron selectively damages the cells that produce reproductive hormones, leading to low testosterone in men and menstrual irregularities or early menopause in women.11PubMed. Endocrine dysfunction in hereditary hemochromatosis Heart muscle can accumulate iron too, causing arrhythmias or heart failure, though this is more typical of the juvenile form than the classical adult form.
The Joint Problem That Phlebotomy Does Not Fix
Arthritis is one of the most frustrating aspects of hemochromatosis because it often persists or worsens even after iron stores have been brought down to normal. The classic pattern targets the knuckle joints of the index and middle fingers, plus the wrists, hips, and ankles. About half of patients show calcium deposits in the cartilage of their wrists and knees on X-rays, a condition known as chondrocalcinosis.12PubMed. HFE-related hemochromatosis: an update for the rheumatologist
Researchers have found that hemochromatosis arthritis shares striking similarities with calcium crystal deposition disease. Both involve low-grade inflammation in the joint lining, similar patterns of affected joints, and generalized bone loss. Excess iron damages cartilage cells, reduces bone-building activity, and increases bone breakdown.13PubMed. Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review The going theory is that once the cartilage damage is done, removing iron cannot reverse it. For many patients, joint symptoms are the reason they sought medical attention in the first place, and also the symptom they are most disappointed to learn treatment will not resolve.
Getting Diagnosed
Two blood tests form the backbone of diagnosis. Transferrin saturation measures how much of the iron-carrying protein in your blood is occupied. A level above 45% raises a red flag. Serum ferritin measures the body’s iron stores and tracks how much iron has accumulated in tissues. Both tests are sensitive and specific for detecting hemochromatosis, whereas serum iron alone is unreliable.14Gastroenterology. Diagnosis of hemochromatosis in young subjects: Predictive accuracy of biochemical screening tests A ferritin level under 1,000 micrograms per liter is a reassuring sign that cirrhosis is unlikely to be present.15PubMed. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians
If iron markers are elevated, genetic testing for HFE mutations confirms the diagnosis. Liver biopsy, once the gold standard, is now reserved mainly for cases where cirrhosis needs to be assessed or the genetic picture is ambiguous. MRI-based iron quantification has largely replaced biopsy for measuring how much iron the liver is carrying.
Whether entire populations should be screened genetically has been argued for decades. Proponents point out that hemochromatosis is common, treatable, and causes irreversible damage if caught late, making it a seemingly ideal candidate for population screening.16PubMed Central. Should we genetically test everyone for haemochromatosis? Opponents counter that the vast majority of people with the genotype never get sick, and mass genetic testing raises concerns about insurance discrimination and psychological harm from a diagnosis that may never matter clinically.17JAMA. Hereditary Hemochromatosis: Gene Discovery and Its Implications for Population-Based Screening Most guidelines currently recommend against routine population-level genetic screening, favoring instead that doctors check iron studies in people with suggestive symptoms or a family history.
Treatment
The mainstay of treatment is phlebotomy, which is just a clinical way of saying therapeutic blood removal. During the induction phase, you give about 350 to 500 milliliters of blood every one to two weeks, essentially the same as a blood donation, until ferritin drops to around 50 micrograms per liter. After that, maintenance phlebotomy two to four times a year keeps ferritin between about 50 and 100.18PubMed Central. Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation19PubMed. EASL Clinical Practice Guidelines on haemochromatosis
Iron chelation drugs, which bind iron so it can be excreted in urine or stool, exist but are not standard for hemochromatosis. Phlebotomy replaced chelation therapy in the 1970s because it is simpler, cheaper, and better tolerated. The oral chelator deferiprone, for example, tends to be poorly tolerated in hemochromatosis patients.20PubMed Central. A Review on Iron Chelators in Treatment of Iron Overload Syndromes Chelators are mainly reserved for the rare patient who cannot tolerate phlebotomy due to anemia or poor venous access.
When treatment starts before cirrhosis has set in, life expectancy is normal. Most organ damage other than joint disease and established cirrhosis can improve or stabilize once iron is brought under control.
What Makes Outcomes Worse
Not every C282Y homozygote who accumulates iron progresses to liver disease at the same rate, and two modifiable factors stand out. Alcohol consumption accelerates liver injury substantially. In a study of hemochromatosis patients, heavy drinking nearly quadrupled the odds of fibrosis independently of how much iron was stored. Fatty liver disease (steatosis) was an equally strong independent risk factor, roughly quadrupling fibrosis risk on its own.21PubMed. Steatosis is a cofactor in liver injury in hemochromatosis The combination of iron overload with alcohol and a fatty liver is a much more dangerous picture than iron overload alone. Reducing or eliminating alcohol is among the most impactful things you can do alongside phlebotomy.
On the dietary side, several food components influence how much iron you absorb. Vitamin C dramatically boosts iron uptake and is generally something to moderate around meals if you have hemochromatosis. Alcohol also stimulates absorption by suppressing hepcidin, giving it a double hit. Meanwhile, tannins from tea and coffee, phytic acid from whole grains and legumes, and calcium from dairy all inhibit iron absorption to varying degrees.22PubMed Central. A Review of Nutrients and Compounds, Which Promote or Inhibit Intestinal Iron Absorption: Making a Platform for Dietary Measures That Can Reduce Iron Uptake in Patients with Genetic Haemochromatosis Drinking tea with meals, for instance, is a simple habit that can meaningfully reduce iron uptake. These dietary strategies do not replace phlebotomy, but they can slow iron re-accumulation between sessions.
Can You Donate the Blood?
A question that comes up often: if the blood being removed is perfectly healthy aside from its iron content, why can’t it be used for transfusions? Biologically, there is nothing wrong with hemochromatosis blood. Studies from Australia’s therapeutic venesection program have confirmed that the blood carries a low infectious disease risk and is a safe and acceptable source of donations.23PubMed. The infectious disease blood safety risk of Australian hemochromatosis donations
Despite this, policies vary enormously around the world. A survey of blood services found that about two-thirds of responding services accept hemochromatosis patients as donors, though the rules on how frequently they can donate and whether a physician prescription is needed differ widely.24PubMed. Worldwide policies on haemochromatosis and blood donation: a survey among blood services In the United States, many blood centers still will not accept blood drawn during therapeutic phlebotomy.25PubMed. Reassessing the safety concerns of utilizing blood donations from patients with hemochromatosis The restrictions are rooted in regulatory caution rather than any evidence that the blood is unsafe. If you have hemochromatosis and want to donate, it is worth checking the specific policy of your local blood service, since the rules are changing in many places.
Why the Mutation Is So Common
A genetic variant that causes a potentially fatal disease does not normally persist at high frequencies in a population unless it once conferred some survival advantage. The C282Y mutation is found at its highest rates in Northern European populations, particularly in Scandinavia, Iceland, and the parts of the British Isles with strong Viking settlement history. Frequencies of the variant are highest along coastlines and decline moving south through Europe, consistent with spread by Norse migration rather than a purely Celtic origin.26PubMed. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings
The leading explanation for positive selection involves climate and diet. In cold, wet Northern Europe, where grain-based diets replaced iron-rich meat during the transition to farming, a mutation that enhanced iron absorption would have been a survival advantage, especially for women during pregnancy and lactation. Research has shown a strong statistical relationship between C282Y frequency and both lower average temperatures and more rainy days per year, supporting the idea that the mutation was selected for in cooler, wetter environments where dietary iron was scarce.27PubMed Central. The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic In modern life, with abundant red meat and iron-fortified foods, that once-helpful trait becomes a liability.
Iron Overload and Infection Risk
Iron is not just fuel for human cells. Bacteria, fungi, and parasites need it too. One of the body’s key defenses against infection is iron restriction: during an acute infection, hepcidin surges to pull iron out of circulation and starve invading microbes. In hemochromatosis, where hepcidin is already low and circulating iron is high, this defense is blunted. The result is heightened susceptibility to certain infections, particularly those caused by organisms that thrive when iron is freely available.28PubMed. Iron and infection Vibrio vulnificus, a bacterium found in raw shellfish and warm coastal waters, is the classic example: it can cause rapidly fatal sepsis in people with iron overload, and eating raw oysters is specifically warned against. Listeria and Yersinia are also on the watch list.
Pregnancy and Hemochromatosis
Pregnancy naturally draws iron from the mother’s stores to support the growing fetus, which often masks hemochromatosis or delays its detection. Iron levels may even normalize during pregnancy and the early postpartum period. But carrying the HFE mutation may still carry risks beyond iron loading itself. Hemochromatosis-associated gene variants appear to increase the co-absorption of lead along with iron, which has been linked to higher rates of preeclampsia, gestational hypertension, and fetal growth problems. There are also preliminary reports of increased risks of neurodevelopmental delays and childhood leukemia in offspring when both mother and child carry HFE mutations.29GastroHep. Primary Hereditary Haemochromatosis and Pregnancy This area of research is still young, and the evidence is largely observational, but it adds weight to the argument that women with known hemochromatosis should have their iron levels monitored during pregnancy rather than assuming the condition is on pause.